"Antifungal Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues.
| Descriptor ID |
D000935
|
| MeSH Number(s) |
D27.505.954.122.136
|
| Concept/Terms |
Antifungal Agents- Antifungal Agents
- Agents, Antifungal
- Therapeutic Fungicides
- Fungicides, Therapeutic
|
Below are MeSH descriptors whose meaning is more general than "Antifungal Agents".
Below are MeSH descriptors whose meaning is more specific than "Antifungal Agents".
This graph shows the total number of publications written about "Antifungal Agents" by people in this website by year, and whether "Antifungal Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 0 | 2 |
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 3 | 4 |
| 1997 | 8 | 5 | 13 |
| 1998 | 1 | 0 | 1 |
| 1999 | 3 | 2 | 5 |
| 2000 | 3 | 4 | 7 |
| 2001 | 6 | 6 | 12 |
| 2002 | 5 | 7 | 12 |
| 2003 | 19 | 5 | 24 |
| 2004 | 11 | 10 | 21 |
| 2005 | 19 | 4 | 23 |
| 2006 | 25 | 8 | 33 |
| 2007 | 13 | 9 | 22 |
| 2008 | 15 | 7 | 22 |
| 2009 | 12 | 7 | 19 |
| 2010 | 15 | 6 | 21 |
| 2011 | 17 | 7 | 24 |
| 2012 | 17 | 16 | 33 |
| 2013 | 12 | 11 | 23 |
| 2014 | 16 | 14 | 30 |
| 2015 | 16 | 9 | 25 |
| 2016 | 16 | 8 | 24 |
| 2017 | 15 | 8 | 23 |
| 2018 | 15 | 10 | 25 |
| 2019 | 13 | 7 | 20 |
| 2020 | 6 | 6 | 12 |
| 2021 | 6 | 13 | 19 |
| 2022 | 3 | 13 | 16 |
| 2023 | 0 | 4 | 4 |
| 2024 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antifungal Agents" by people in Profiles.
-
Translational genetics identifies a phosphorylation switch in CARD9 required for innate inflammatory responses. Cell Rep. 2024 Mar 26; 43(3):113944.
-
A novel lentiviral vector-based approach to generate chimeric antigen receptor T cells targeting Aspergillus fumigatus. mBio. 2024 Apr 10; 15(4):e0341323.
-
Invasive fusariosis in patients with leukaemia in the era of mould-active azoles: increasing incidence, frequent breakthrough infections and lack of improved outcomes. J Antimicrob Chemother. 2024 Feb 01; 79(2):297-306.
-
Liquid Chromatography-Tandem Mass Spectrometry-Based Therapeutic Monitoring of Plasma Atovaquone Concentrations in Pediatric Patients. Methods Mol Biol. 2024; 2737:67-77.
-
Adjunctive Diagnostic Studies Completed Following Detection of Candidemia in Children: Secondary Analysis of Observed Practice From a Multicenter Cohort Study Conducted by the Pediatric Fungal Network. J Pediatric Infect Dis Soc. 2023 Sep 27; 12(9):487-495.
-
Mucormycosis in 2023: an update on pathogenesis and management. Front Cell Infect Microbiol. 2023; 13:1254919.
-
Micafungin pharmacodynamics predict clinical outcomes in hospitalized patients with candidemia caused by certain Candida species. Pharmacotherapy. 2023 06; 43(6):466-472.
-
Development of a Corticosteroid-Immunosuppressed Mouse Model to Study the Pathogenesis and Therapy of Influenza-Associated Pulmonary Aspergillosis. J Infect Dis. 2023 04 12; 227(7):901-906.
-
Osteoarticular Mycoses. Clin Microbiol Rev. 2022 12 21; 35(4):e0008619.
-
Comparison of Mold Active Triazoles as Primary Antifungal Prophylaxis in Patients With Newly Diagnosed Acute Myeloid Leukemia in the Era of Molecularly Targeted Therapies. Clin Infect Dis. 2022 Oct 29; 75(9):1503-1510.